Skip to main content
. 2023 Nov 8;165(2):291–299. doi: 10.1007/s11060-023-04482-5

Table 1.

Indication for first diagnostic scan

Indication for scan* 2008–2009 2018–2019
Age < 70** Age ≥ 70*** Age < 70** Age ≥70***
Headache, n (%) 7 (13.2) 3 (3.9) 4 (9) 2 (1.7)
Cerebrovascular incident, n (%) 3 (5.7) 25 (32.9) 5 (11.1) 23 (19.8)
Head injury, n (%) 13 (24.5) 14 (18.4) 10 (22.2) 30 (26)
Audiovestibular symptoms, n (%) 1 (1.9) 1 (1.3) 0 (0) 1 (0.9)
Visual symptoms, n (%) 1 (1.9) 2 (2.6) 5 (11.1) 2 (1.7)
Psychiatric symptoms, n (%) 3 (5.7) 2 (2.6) 1 (2.2) 3 (2.6)
Cognitive symptoms, n (%) 0 (0) 9 (11.8) 1 (2.2) 14 (12.1)
Loss of consciousness, n (%) 1 (1.9) 4 (5.2) 0 (0) 7 (6)
Vertigo, n (%) 7 (13.6) 10 (13.1) 2 (4.4) 7 (6)
Lethargy, n (%) 1 (1.9) 2 (2.6) 1 (2.2) 5 (4.3)
Scan for metastases, n (%) 4 (7.5) 0 (0) 4 (9) 12 (10.3)
Other ****, n (%) 12 (22.6) 4 (5.2) 12 (26.6) 10 (8.6)

*Symptoms deemed not associated with the meningioma in question

** p = 0.5

*** p = 0.046

**** Data on “other” available in Supplementary Table 1